DISEASE MARKERS

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

DISEASE MARKERS

DIS MARKERS

ISSN / eISSN

0278-0240 / 1875-8630

Aims and Scope

Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.

Subject Area

N/A

CiteScore

3.70

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Biochemistry (medical)	Q3	#36/65
Medicine - Genetics	Q3	#211/328
Medicine - Clinical Biochemistry	Q3	#79/113
Medicine - Molecular Biology	Q3	#281/380

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
-	-

H-index

Country/Area of Publication

NETHERLANDS

Publisher

Hindawi Limited

Publication Frequency

Bimonthly

Year Publication Started

1983

Annual Article Volume

241

Open Access

YES

Contact

IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG

Popular journals in the same field
Recent articles

Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis: (2023) Shoko Miyamoto, Yasutomo Imai, Masako Matsutani, Makoto Nagai, Kiyofumi Yamanishi, Nobuo Kanazawa, Shin Nishiumi

Retracted: Neurotransmitters and Electrophysiological Changes Might Work as Biomarkers for Diagnosing Affective Disorders: (2023) Disease Markers

Meta-Analysis of Assessment of Total Oxidative Stress and Total Antioxidant Capacity in Patients with Periodontitis: (2023) Khadijah Mohideen, Krithika Chandrasekaran, Harsha Veeraraghavan, Shahul Hameed Faizee, Safal Dhungel, Snehashish Ghosh

Retracted: Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression: (2023) Disease Markers

Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation: (2023) Yasmin Mohtasham Kia, Alessandro Cannavo, Pegah Bahiraie, Sanam Alilou, Behrad Saeedian, Nastaran Babajani, Elina Ghondaghsaz, Amirmohammad Khalaji, A...

Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer: (2023) Qing Li, Zongjing Yang, Xingqing Ling, Junming Ye, Jiaying Wu, Yu Wang, Chun Yao, Jinghui Zheng

Retracted: CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4: (2023) Disease Markers

Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma: (2023) Disease Markers

Retracted: Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren’s Syndrome Based on the PI3K/Akt/HIF-1α/VEGF Signaling Pathway: (2023) Disease Markers

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492: (2023) Zhenzhen Feng, Jiyuan Wu

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

Can you please reject the manuscript faster? It has been hanging for 3 months without being assigned for initial review, and then the initial review takes nearly another month. I estimate that it takes about half a month for the initial reviewer to even take a glance at the manuscript. It only took a month to reject the revised manuscript!

2022-08-03

After more than a month of initial review, I made significant revisions and resubmitted the article. It was basically accepted. I submitted a clinical retrospective article, and this journal does not have too many publications, so it is relatively niche. Overall, it is fine, and the review requirements are not too strict.

2022-06-25

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started